Advanced imaging in neuroimmunological diseases (ImaginEM)
Featured publications
-
Clinical characterisation of patients in the post-acute stage of anti-NMDA receptor encephalitis: a prospective cohort study and comparison with patients with schizophrenia spectrum disorders
Guasp, M; Rosa-Justicia, M; Muñoz-Lopetegi, A; Martínez-Hernández, E; Armangué, T;(...)Sánchez-Valle, R; Santamaria, J; Compte, A; Castro-Fornielest, J; Dalmau, J.Reference:Lancet Neurology 2022.
-
Dynamics and Predictors of Cognitive Impairment along the Disease Course in Multiple Sclerosis
Lopez-Soley, Elisabet; Martinez-Heras, Eloy; Andorra, Magi; Solanes, Aleix; Radua, Joaquim;(...)Martinez-Lapiscina, Elena H; Villoslada, Pablo; Saiz, Albert; Solana, Elisabeth; Llufriu, Sara.Reference:J Pers Med 2021.
-
Oligoclonal IgM bands in the cerebrospinal fluid of patients with relapsing MS to inform long-term MS disability
Capuano, Rocco; Zubizarreta, Irati; Alba-Arbalat, Salut; Sepulveda, Maria; Sola-Valls, Nuria;(...)Villoslada, Pablo; Saiz, Albert; Llufriu, Sara; Villar, Luisa M; Martinez-Lapiscina, Elena H.Reference:Multiple Sclerosis Journal 2021.
-
Regional grey matter microstructural changes and volume loss according to disease duration in multiple sclerosis patients
Solana, Elisabeth; Martinez-Heras, Eloy; Montal, Victor; Vilaplana, Eduard; Lopez-Soley, Elisabet;(...)Martinez-Lapiscina, E H; Prados, Ferran; Saiz, Albert; Fortea, Juan; Llufriu, Sara.Reference:Scientific Reports 2021.
-
Incidence and Impact of COVID-19 in MS: A Survey From a Barcelona MS Unit
Sepulveda, Maria; Llufriu, Sara; Martinez-Hernandez, Eugenia; Catala, Marti; Artola, Montse;(...)Aldea, Marta; Prats, Clara; Graus, Francesc; Blanco, Yolanda; Saiz, Albert.Reference:Neurology-Neuroimmunology & Neuroinflammation 2021.
-
Retinal and brain damage during multiple sclerosis course: inflammatory activity is a key factor in the first 5 years
Pulido-Valdeolivas, Irene; Andorra, Magi; Gomez-Andres, David; Nakamura, Kunio; Alba-Arbalat, Salut;(...)Camos-Carreras, Anna; Sanchez-Dalmau, Bernardo; Villoslada, Pablo; Saiz, Albert; Martinez-Lapiscina, Elena H.Reference:Scientific Reports 2020.
-
Characterization of multiple sclerosis lesions with distinct clinical correlates through quantitative diffusion MRI
Martinez-Heras, Eloy; Solana, Elisabeth; Prados, Ferran; Andorra, Magi; Solanes, Aleix;(...)Sepulveda, Maria; Blanco, Yolanda; Saiz, Albert; Radua, Joaquim; Llufriu, Sara.Reference:Neuroimage-Clinical 2020.
-
Late-onset neuromyelitis optica spectrum disorder: The importance of autoantibody serostatus
Sepulveda, M; Delgado-García, G; Blanco, Y; Sola-Valls, N; Martinez-Lapiscina, EH;(...)Llufriu, S; Dalmau, J; Graus, F; Saiz, A; Ruiz-García, R.Reference:Neurology-Neuroimmunology & Neuroinflammation 2019.
-
Immune tolerance in multiple sclerosis and neuromyelitis optica with peptide-loaded tolerogenic dendritic cells in a phase 1b trial
Zubizarreta, Irati; Florez-Grau, Georgina; Vila, Gemma; Cabezon, Raquel; Espana, Carolina;(...)Lozano, Miquel; Blanco, Yolanda; Steinman, Lawrence; Benitez-Ribas, Daniel; Villoslada, Pablo.Reference:Proceedings Of The National Academy Of Sciences Of The United States Of America 2019.
-
Assessing Biological and Methodological Aspects of Brain Volume Loss in Multiple Sclerosis.
Andorra, Magi; Nakamura, Kunio; Lampert, Erika J; Pulido-Valdeolivas, Irene; Zubizarreta, Irati;(...)Tercero-Uribe, Ana; Blanco, Yolanda; Saiz, Albert; Villoslada, Pablo; Martinez-Lapiscina, Elena H.Reference:Jama Neurology 2018.